Risk factors for Clostridium difficile infection

Journal of Hospital Infection

Volumn 40, Issue 1, 1998, Pages 1-15

  Bignardi, G E ^a  

^a SUNDERLAND ROYAL HOSPITAL   (United Kingdom)

Author keywords

Antibiotics; C. difficile; Meta analysis

Indexed keywords

AMOXICILLIN; AMOXICILLIN PLUS CLAVULANIC ACID; ANTIULCER AGENT; AZTREONAM; CEFACLOR; CEFAMANDOLE; CEFONICID; CEFOTAXIME; CEFOXITIN; CEFTAZIDIME; CEFTRIAXONE; CEFUROXIME; CEPHALOSPORIN; CIPROFLOXACIN; CLINDAMYCIN; COTRIMOXAZOLE; ERYTHROMYCIN; IMIPENEM; LINCOMYCIN; LINCOSAMIDE; METRONIDAZOLE; MEZLOCILLIN; NITROFURANTOIN; PENICILLIN G; PRISTINAMYCIN; QUINOLONE DERIVATIVE; SPIRAMYCIN; TETRACYCLINE; UNINDEXED DRUG; VANCOMYCIN;

AGE; ANTIBIOTIC THERAPY; ARTICLE; BACTERIAL INFECTION; CLINICAL TRIAL; CLOSTRIDIUM DIFFICILE; DIARRHEA; DISEASE COURSE; DISEASE SEVERITY; DOUBLE BLIND PROCEDURE; DRUG COMBINATION; GASTROINTESTINAL DISEASE; HEMATOLOGY; HOSPITALIZATION; HUMAN; INTENSIVE CARE UNIT; MALIGNANT NEOPLASTIC DISEASE; META ANALYSIS; NASOGASTRIC TUBE; PSEUDOMONAS; REGRESSION ANALYSIS; RISK FACTOR; STAPHYLOCOCCUS INFECTION;

EID: 0031752883     PISSN: 01956701     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0195-6701(98)90019-6     Document Type: Review

References (59)

1. Clostridium difficile infection. Prevention and Management. A report by Department of Health/Public Health Laboratory Service Joint Working Group. Heywood, Lancashire: BAPS Health Publications Unit, 1994; 1-49.
2. Hospital Infection Working Group of the Department of Health and Public Health Laboratory Service. Hospital Infection Control. Guidance on the Control of Infection in Hospitals, Heywood: BAPS Health Publications Unit, 1995; 1-84.
3. Francis B, Green M, Payne C. (eds). The GLIM System Release 4 Manual. Oxford: Clarendon Press, 1993.
4. Pierce Jr PF, Wilson R, Silva Jr J et al. Antibiotic-associated pseudomembranous colitis: an epidemiologic investigation of a cluster of cases. J Infect Dis 1982; 145: 269-274.
5. Keighley MRB, Ambrose NS, Morris DL, Burdon DW. Evaluation of mezlocillin in elective gastrointestinal surgery. J Antimicrob Chemother 1983; 11 (Suppl. C): 65-69.
6. Kirkpatrick JR, Anderson BJ, Louie JJ, Stiver HG. Double-blind comparison of metronidazole plus gentamicin and clindamycin plus gentamicin in intra-abdominal infection. Surgery 1983; 93: 215-216.
7. Aronsson B, Mölby R, Nord CE. Diagnosis and epidemiology of Clostridium difficile enterocolitis in Sweden. J Antimicrob Chemother 1984; 14 (Suppl. D): 85-95.
8. Morris Jr JG, Jarvis WR, Nunez-Montiel OL et al. Clostridium difficile. Colonization and toxin production in a cohort of patients with malignant hematologic disorders. Arch Intern Med 1984; 144: 967-969.
9. Aronsson B, Möllby R, Nord CE. Antimicrobial agents and Clostridium difficile in acute enteric disease: epidemiological data from Sweden, 1980-1982. J Infect Dis 1985; 151: 476-481.
10. Geroulanos S, Donfried B, Schumacher F, Turina M. Cefuroxime versus ceftriaxone prophylaxis in cardiovascular surgery. Drugs Exp Clin Res 1985; 11: 201-205.
11. Hall SM, Calver GP, Williams M. A hospital outbreak of Clostridium difficile? J Hosp Infect 1985; 6: 312-322.
12. Gerding DN, Olson MM, Peterson LR et al. Clostridium difficile-associated diarrhea and colitis in adults. A prospective case-controlled epidemiologic study. Arch Intern Med 1986; 146: 95-100.
13. Hackford AW, Tally FP, Reinhold RB, Barza M, Gorbach SL. Prospective study comparing imipenem-cilastin with clindamycin and gentamycin for the treatment of serious surgical infections. Arch Surg 1988; 123: 322-326.
14. Heard SR, Wren B, Barnett MJ, Thomas JM, Tabaqchali S. Clostridium difficile infection in patients with haematological malignant disease. Epidemiol Infect 1988; 100: 63-72.
15. Ambrose NS. The effects of single doses of antibiotics on faecal flora with reference to their mode of excretion. J Drug Dev 1989; 1: 233-241.
16. de Lalla F, Privitera G, Ortisi G et al. Third generation cephalosporins as a risk factor for Clostridium difficile-associated disease: a fouryear survey in a general hospital. J Antimicrob Chemother 1989; 23: 623-631.
17. Golledge CL, McKenzie T, Riley TV. Extended spectrum cephalosporins and Clostridium difficile. J Antimicrob Chemother 1989; 23: 929-931.
18. McFarland LV, Mulligan ME, Kwok RYY, Stamm WE. Nosocomial acquisition of Clostridium difficile infection. N Engl J Med 1989; 320: 204-210.
19. Surawicz CM, Elmer GW, Speelman P, McFarland L, Chinn J, van Belle G. Prevention of antibiotic-associated diarrhoea by Saccharomyces boulardii: a prospective study. Gastroenterology 1989; 96: 981-988.
20. Brown E, Talbot GH, Axelrod P, Provencher M, Hoegg C. Risk factors for Clostridium difficile toxin-associated diarrhoea. Infect Control Hosp Epidemiol 1990; 11: 283-290.
21. Gelfand MS, Simmons BP, Schoettle P et al. Cefamandole versus cefonicid prophylaxis in cardiovascular surgery: a prospective study. Ann Thorac Surg 1990; 49: 435-439.
22. Johnson S, Gerding DN, Olson MM et al. Prospective, controlled study of vinyl glove use to interrupt Clostridium difficile nosocomial transmission. Am J Med 1990; 88: 137-140.
23. McFarland LV, Surawicz CM, Stamm WE. Risk factors for Clostridium difficile carriage and C. difficile-associated diarrhea in a cohort of hospitalized patients. J Infect Dis 1990; 162: 678-684.
24. Thomas DR, Bennett RG, Laughon BE, Greenough WB, Bartlett JG. Postantibiotic colonisation with Clostridium difficile in nursing home patients. J Am Geriatr Soc 1990; 38: 415-420.
25. Eriksson S, Aronsson B. Cephalosporins predominantly implicated in Clostridium difficileassociated infections. Läkartidningen 1991; 88: 3374-3379.
26. Privitera G, Scarpellini P, Ortisi G, Nicastro G, Nicolin R, de Lalla F. Prospective study of Clostridium difficile intestinal colonisation following single-dose antibiotic prophylaxis in surgery. Antimicrob Agents Chemother 1991; 35: 208-210.
27. Thibault A, Miller MA, Gaese C. Risk factors for the development of Clostridium difficile-associated diarrhoea during a hospital outbreak. Infect Control Hosp Epidemiol 1991; 12: 345-348.
28. Hutin Y, Molina JM, Casin I. Risk factors for Clostridium difficile-associated diarrhoea in HIV-infected patients. AIDS 1993; 7: 1441-1447.
29. Rudensky B, Rosner S, Sonnenblick M, van Dijk Y, Shapira E, Isaacsohn M. The prevalence and nosocomial acquisition of Clostridium difficile in elderly hospitalised patients. Postgrad Med J 1993; 69: 45-47.
30. Simor AE, Yake SL, Tsimidis K. Infection due to Clostridium difficile among elderly residents of a long-term care facility. Clin Infect Dis 1993; 17: 672-678.
31. Talbot GH, Cassileth PA, Paradiso L, CorreaCoronas R, Bond L, Enoxacin Prophylaxis Study Group. Oral enoxacin for infection prevention in adults with acute nonlymphocytic leukemia. Antimicrob Agents Chemother 1993; 37: 474-482.
32. Walker KJ, Gilliland SS, Vance-Bryan K et al. Clostridium difficile colonisation in residents of long-term care facilities: prevalence and risk factors. J Am Geriatr Soc 1993; 41: 940-946.
33. Anand A, Bashey B, Mir T, Glatt AE. Epidemiology, clinical manifestations, and outcome of Clostridium difficile-associated diarrhea. Am J Gastroenterol 1994; 89: 519-523.
34. Hirschhorn LR, Trnka Y, Onderdonk A, Lee M-LT, Platt R. Epidemiology of communityacquired Clostridium difficile-associated diarrhea. J Infect Dis 1994; 169: 127-133.
35. Nath SK, Salama S, Persaud D et al. Drug risk factors associated with a sustained outbreak of Clostridium difficile diarrhea in a teaching hospital. Can J Infect Dis 1994; 5: 270-274.
36. Nelson DE, Auerbach SB, Baltch AL et al. Epidemic Clostridium difficile-associated diarrhea: role of second- and third-generation cephalosporins. Infect Control Hosp Epidemiol 1994; 15: 88-94. (Published erratum in Infect Control Hosp Epidemiol 1994; 15: 366).
37. Palmbach W, Heizman WR, Decker K. Incidence and role of Clostridium difficile in patients treated with various antibiotics for therapeutic reasons or with cefoxitin as perioperative prophylaxis. Geburtshilfe Frauenheilkd 54: 84-88.
38. Pear SM, Williamson TH, Bettin KM, Gerding DN, Galgiani JN. Decrease in nosocomial Clostridium difficile-associated diarrhea by restricting clindamycin use. Ann Intern Med 1994; 120: 272-277.
39. Samore MH, DeGirolami PC, Tlucko A, Lichtenberg DA, Melvin ZA, Karchmer AW. Clostridium difficile colonization and diarrhoea at a tertiary care hospital. Clin Infect Dis 1994; 18: 181-187.
40. Tacconelli E, Leone F, Mazzella P, Tumbarello M. Clostridium difficile associated diarrhea: two years of observation in a University Hospital. L'Igiene Moderna 1994; 102: 95-104.
41. Barthram JD, Dunstan FDJ, Hill D, Hosein IK, Pippen CAR. Clostridium difficile: the association between antibiotic therapy and the incidence of infection in the elderly. Pharmaceut J 1995; 255: 276-278.
42. Impallomeni M, Galletly NP, Wort SJ, Starr JM, Rogers TR. Increased risk of diarrhoea caused by Clostridium difficile in elderly patients receiving cefotaxime. Br Med J 1995; 311: 1345-1346.
43. Jobe BA, Grasley A, Deveney KE, Deveney CW, Sheppard BC. Clostridium difficile colitis: an increasing hospital-acquired illness. Am J Surg 1995; 169: 480-483.
44. Kreisel D, Savel TG, Silver AL, Cunningham JD. Surgical antibiotic prophylaxis and Clostridium difficile toxin positivity. Arch Surg 1995; 130: 989-993.
45. Lew MA, Kehoe K, Ritz J et al. Ciprofloxacin versus trimethoprim/sulfamethoxazole for prophylaxis of bacterial infections in bone marrow transplant recipients: a randomized, controlled trial. J Clin Oncol 1995; 13: 239-250.
46. McFarland LV, Surawicz CM, Greenberg RN et al. Prevention of β-lactam-associated diarrhoea by Saccharomyces boulardii compared with placebo. Am J Gastroenterol 1995; 90: 439-448.
47. Macgowan AP, Brown I, Feeney R et al. Clostridium difficile-associated diarrhoea and length of hospital stay. J Hosp Infect 1995; 31: 241-244.
48. Riley TV, Codde JP, Rouse IL. Increased length of hospital stay due to Clostridium difficile associated diarrhoea. Lancet 1995; 345: 455-456.
49. Schuller I, Saha V, Lin L, Kingston J, Eden T, Tabaqchali S. Investigation and management of Clostridium difficile colonisation in a pediatric oncology unit. Arch Dis Child 1995; 72: 219-222.
50. Talon D, Bailly P, Delmée M et al. Use of pulsed-field gel electrophoresis for investigation of an outbreak of Clostridium difficile infection among geriatric patients. Eur J Clin Microbiol Infect Dis 1995; 14: 987-993.
51. Tumbarello M, Tacconelli E, Leone F, Cauda R, Ortona L. Clostridium difficile-associated diarrhoea in patients with human immunodeficiency virus infection: a case-control study. Eur J Gastroenterol Hepatol 1995; 7: 259-263.
52. Thamlikitkul V, Danpakdi K, Chokloikaew S. Incidence of diarrhoea and Clostridium difficile toxin in stools from hospitalized patients receiving clindamycin, beta-lactams, or nonantibiotic medications. J Clin Gastroenterol 1996; 22: 161-163.
53. Zimmerman RK. Risk factors for Clostridium difficile cytotoxin-positive diarrhoea after control for horizontal transmission. Infect Control Hosp Epidemiol 1991; 12: 96-100.
54. Bonnefoy A, Popoff MR. Prevalence of Clostridium difficile in HIV infected patients. Méd Mal Infect 1992; 22: 9-13.
55. Jensen GL, Bross JE, Bourbeau PP, Naumovitz DW, Streater M, Gianferante LE. Risk factors for Clostridium difficile stool cytotoxin B among critically ill patients: role of sucralfate. J Infect Dis 1994; 170: 227-230.
56. Cooper GS, Lederman MMM, Salata RA. A predictive model to identify Clostridium difficile toxin in hospitalized patients with diarrhea. Am J Gastroenterol 1995; 91: 80-84.
57. Manabe YC, Vinetz JM, Moore RD, Merz C, Charache P, Bartlett JG. Clostridium difficile colitis: an efficient clinical approach to diagnosis. Ann Intern Med 1995; 123: 835-40.
58. McFarland LV. Epidemiology of infectious and iatrogenic nosocomial diarrhea in a cohort of general medicine patients. Am J Infect Control 1995; 23: 295-305.
59. Rubin MS, Bodenstein LE, Kent KC. Severe Clostridium difficile colitis. Dis Colon Rectum 1995; 38: 350-354.